SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer

About SciSparc Ltd. (Nasdaq: SPRC): This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. For example, SciSparc is using forward-looking statements when it discusses the potential significant role of MitoCareX's drug target in NSCLC, the projected size of the NSCLC market, and that MitoCareX's AI model is expected to enable MitoCareX to navigate broader chemical spac ...